This page includes the latest FDA filings for Bridgebio Pharma Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | BBIO | DUNS 117109644 |
Device Company | Device | Date |
|---|---|---|
| BridgeBio Pharma, Inc. | Prescription Medication | 2025-12-16 |
| BridgeBio Pharma, Inc. | Prescription Medication | 2025-09-07 |
| BridgeBio Pharma, Inc. | Prescription Medication | 2025-08-09 |
| BridgeBio Pharma, Inc. | Prescription Medication | 2025-05-15 |
| BridgeBio Pharma, Inc. | Prescription Medication | 2024-11-27 |
| NCAGE Code | 8FVJ9 | BRIDGEBIO PHARMA, INC. |
| CAGE Code | 8FVJ9 | BRIDGEBIO PHARMA, INC. |
| SEC | 0001743881 | BridgeBio Pharma, Inc. of DELAWARE |